, CHAPTER LIST
Section I: The Neuroscience Model
Chapter 1: Introduction
Chapter 2: Neuroanatomy
Chapter 3: Cells and Circuits
Chapter 4: Neurotransmitters
Chapter 5: Receptors and Signaling the Nucleus
Chapter 6: Genetics and Epigenetics
Section II: Modulators
Chapter 7: Hormones and the Brain
Chapter 8: Plasticity and Adult Development
Chapter 9: Immunity and Inflammation
Chapter 10: The Electrical Brain
Section III: Behaviors
Chapter 11: Pain
Chapter 12: Pleasure
Chapter 13: Appetite
Chapter 14: Anger and Aggression
Chapter 15: Sleep
Chapter 16: Sex and the Brain
Chapter 17: Social Attachment
Chapter 18: Memory
Chapter 19: Intelligence
Chapter 20: Attention
Section IV: Disorders
Chapter 21: Depression
Chapter 22: Anxiety
Chapter 23: Schizophrenia
Chapter 24: Alzheimer’s Disease
,Section I: The Neuroscience Model
Chapter 1: Introduction
Question Quota: 25 MCQs (Q1–Q25) | Question Mix: Mechanism→Symptom (6), Pharmacology (5), Circuitry (5), Discrimination
(3), Case Scenarios (4), Structure/Cascade (2)
Q1. The historical doctrine of mind-brain dualism is clinically problematic in modern psychiatry primarily
because it:
A. Prevents clinicians from identifying the discrete somatic causes of conversion reactions.
B. Restricts psychiatric treatment options exclusively to invasive neurosurgical interventions.
C. Assumes all mental disorders stem from structural chromosomal aneuploidies.
D. Artificially separates psychiatric conditions from verifiable neurobiological dysfunctions.
Answer: D
Rationale: Mind-brain dualism conceptually divorces mental experiences from their underlying physical substrate, creating an
artificial divide between psychiatric and medical illnesses. Modern clinical neuroscience demonstrates that psychiatric symptoms are
direct manifestations of altered neural circuitry, cellular physiology, and neurochemistry, establishing psychiatry as a clinical
neuroscience.
Q2. Framing psychiatric illnesses as disorders of 'pathophysiology' rather than purely psychological reactions is
crucial because it:
A. Ensures that all psychiatric diagnoses can be confirmed via standard laboratory blood tests.
B. Proves that mental illness is caused by macroscopic focal brain tumors.
C. Eliminates the necessity for behavioral therapies in psychiatric treatment plans.
D. Grounds clinical symptoms in identifiable disruptions of neural circuits and molecular cascades.
,Answer: D
Rationale: Conceptualizing psychiatric illnesses through a pathophysiological lens aligns psychiatry with general medicine by
treating behavioral and emotional symptoms as measurable alterations in brain physiology. This mechanistic approach links clinical
phenomena to quantifiable abnormalities in neurotransmitter signaling, neural network connectivity, and neuroplasticity.
Q3. A major clinical limitation of relying solely on the DSM's descriptive diagnostic framework is that it:
A. Mandates invasive neuroimaging prior to assigning any psychiatric diagnosis.
B. Lacks standardized diagnostic criteria across different clinical practice settings.
C. Groups biologically heterogeneous conditions under shared superficial symptom clusters.
D. Overemphasizes underlying neurogenetic etiology at the expense of clinical observation.
Answer: C
Rationale: The DSM relies on descriptive, syndromic criteria rather than etiological mechanisms, meaning patients presenting with
the same categorical diagnosis (such as major depressive disorder) may have distinct underlying biological circuit abnormalities. This
phenomenological grouping limits the ability to target therapies to specific pathophysiology.
Q4. Why does neuroscience serve as the foundational basic science for clinical psychiatry?
A. It demonstrates that every psychiatric symptom originates in a single peripheral nerve.
B. It establishes that psychiatric medications alter mental states without changing neural tissue.
C. It replaces clinical interviews entirely with automated algorithmic scoring.
D. It provides the mechanistic framework for how brain alterations produce disordered behavior.
Answer: D
Rationale: Just as general physiology serves as the foundational science explaining clinical pathology in internal medicine,
neuroscience provides the mechanistic models linking brain anatomy, circuitry, and neurochemistry to psychiatric symptoms.
Understanding these biological principles enables clinicians to understand the rationale behind somatic and psychological
interventions.
Q5. Organizing psychiatric understanding around brain circuits rather than isolated neurotransmitters is essential
because:
, A. Complex behavioral phenotypes emerge from coordinated distributed neural network activity.
B. Circuit models eliminate the role of intracellular second-messenger signaling.
C. Synaptic transmission occurs exclusively through electrical gap junctions without chemical ligands.
D. Neurotransmitters are absent in the central nervous systems of psychiatric patients.
Answer: A
Rationale: Psychiatric functions such as mood regulation, executive control, and threat processing are mediated by distributed,
interconnected neural networks rather than isolated chemical pools. Neurotransmitters act as modulators within these specific circuits,
meaning clinical symptoms reflect network-level circuit dysfunction rather than simple global chemical imbalances.
Q6. How does the biological model of psychiatry conceptualize the relationship between psychotherapy and
neurobiology?
A. Psychotherapy acts exclusively by suppressing hypothalamic endocrine release without cortical involvement.
B. Psychotherapy is considered biologically ineffective compared to surgical lesions.
C. Psychotherapy induces measurable, lasting modifications in neural plasticity and circuit synaptic strength.
D. Psychotherapy works independently of neurobiology without inducing any physical brain changes.
Answer: C
Rationale: The modern biological framework recognizes that learning, psychotherapy, and environmental experiences are biological
events that alter gene expression, synaptic remodeling, and neural circuit connectivity. Functional imaging demonstrates that
successful psychotherapy normalizes dysfunctional neural circuit activity similarly to pharmacotherapy.
Q7. When evaluating psychotropic drug action within a circuit-based framework, pharmacological efficacy
primarily depends on:
A. Irreversibly inhibiting all post-synaptic voltage-gated ion channels.
B. Inducing widespread neuronal apoptosis throughout the subcortical white matter.
C. Maximizing non-specific systemic distribution across non-neuronal organ systems.
D. Altering neurotransmission at specific synapses embedded within symptom-relevant neural loops.
,Answer: D
Rationale: Psychotropic medications exert their therapeutic effects by modulating chemical signaling at critical nodes within
dysfunctional circuits (such as frontostriatal or limbic loops). The therapeutic response is determined by how receptor-level actions
alter overall circuit throughput and downstream gene expression.
Q8. The delayed clinical onset of classical antidepressants, despite rapid reuptake inhibition, illustrates that
therapeutic response involves:
A. Immediate saturation of peripheral plasma albumin binding sites.
B. Permanent elimination of monoamine catabolic enzymes in the liver.
C. Gradual downstream neuroplastic adaptations and intracellular signaling changes.
D. Acute osmotic shifts across the blood-brain barrier endothelial cells.
Answer: C
Rationale: Although monoamine reuptake blockade occurs within hours, clinical improvement requires days to weeks because
therapeutic efficacy depends on downstream neurobiological adaptations. These include receptor down-regulation, cyclic AMP
response element-binding protein (CREB) activation, and brain-derived neurotrophic factor (BDNF) synthesis that restore circuit
integrity.
Q9. A fundamental limitation of the historical 'chemical imbalance' hypothesis of mental illness is that it:
A. Fails to acknowledge that psychotropic drugs bind to central nervous system receptors.
B. Overlooks the complex anatomical distribution and circuit-specific function of neurotransmitters.
C. Assumes neurotransmitters are synthesized exclusively within glial mitochondria.
D. Suggests that psychiatric disorders have higher heritability than neurological diseases.
Answer: B
Rationale: The simplistic 'chemical imbalance' model treats the brain as a homogeneous neurochemical soup, ignoring the fact that
neurotransmitters perform distinct, often opposing functions depending on the specific anatomical circuit and receptor subtype
involved. Effective psychopharmacology requires mapping drug actions onto functional neural circuits.
Q10. Why is understanding receptor subtype diversity critical for modern psychiatric drug development?
, A. It proves that all G-protein-coupled receptors activate identical intracellular pathways.
B. It enables targeting specific circuit components while minimizing off-target adverse effects.
C. It ensures that a single compound can irreversibly block all central nervous system transmission.
D. It eliminates the need to consider drug metabolism in the hepatic cytochrome system.
Answer: B
Rationale: Different receptor subtypes for a given neurotransmitter (e.g., 5-HT1A vs. 5-HT2A) are distributed across distinct brain
regions and couple to different effector cascades. Selective targeting of specific subtypes allows for modulation of targeted neural
pathways while reducing unwanted side effects mediated by other subtypes.
Q11. In the hierarchical neuroscience framework of psychiatry, modulatory systems (such as endocrine and
immune signals):
A. Prevent psychotropic medications from crossing the blood-brain barrier.
B. Operate completely isolated from central neurotransmitter pathways.
C. Directly replace the function of post-synaptic ionotropic receptors.
D. Act as upstream regulators that tune neural circuit excitability and synaptic plasticity.
Answer: D
Rationale: Modulatory systems—including glucocorticoids, gonadal steroids, and circulating cytokines—dynamically adjust the
baseline excitability, gene transcription, and structural plasticity of central neural circuits. Dysregulation in these modulatory systems
can precipitate or exacerbate psychiatric circuit dysfunction.
Q12. Under the organizational architecture of clinical neuroscience, which sequence reflects the hierarchy of
nervous system organization?
A. Modulatory systems → Chemistry → Behaviors → Cells and circuits → Macroscopic structures
B. Chemistry → Behaviors → Macroscopic structures → Cells and circuits → Modulators
C. Macroscopic structures → Cells and circuits → Chemistry → Modulatory systems → Behaviors
D. Behaviors → Modulatory systems → Macroscopic structures → Chemistry → Cells and circuits
,Answer: C
Rationale: The neuroscience framework builds hierarchically from foundational neuroanatomy (macroscopic structures) to
microscopic units (cells and circuits), synaptic transmission (chemistry), systemic tuning (modulators), and ultimately complex
observable phenomena (behaviors and clinical disorders).
Q13. In the circuit-based paradigm of mental illness, psychiatric symptoms are best characterized as:
A. Functional dysregulations within distributed, reciprocal cortico-subcortical loops.
B. Isolated peripheral neuropathies mimicking central nervous system disease.
C. Focal tissue necrosis strictly confined to primary sensory cortices.
D. Static developmental arrests that remain completely immutable to intervention.
Answer: A
Rationale: Psychiatric disorders represent dynamic disruptions in the balance, connectivity, and throughput of cortico-striatal-
thalamo-cortical and limbic-cortical networks. Symptoms reflect dysregulated communication between regulatory cortical regions and
subcortical processing hubs.
Q14. Which structural level provides the essential bridge connecting cellular neurochemistry to clinical behavior?
A. Microvascular capillary basement membranes.
B. Peripheral neuromuscular junction motor endplates.
C. Cerebrospinal fluid osmolarity gradients.
D. Integrated neural circuits and functional networks.
Answer: D
Rationale: Neural circuits and microcircuits integrate cellular and chemical events into functional computational units. These
networks process information and generate the complex cognitive, affective, and motor outputs that constitute human behavior.
Q15. A key premise of circuit-based psychiatry is that distinct psychiatric disorders with overlapping symptoms
frequently share:
, A. Identical macroscopic brainstem infarctions.
B. Common nodes of dysfunction within shared underlying neural networks.
C. Monogenic point mutations on the exact same chromosomal locus.
D. Universal complete absence of cortical gray matter.
Answer: B
Rationale: Symptom overlap across DSM categories (such as executive dysfunction or affective blunting in both depression and
schizophrenia) occurs because disparate pathophysiological processes can converge upon and impair the same underlying neural
circuits (e.g., the frontoparietal or mesocorticolimbic networks).
Q16. The organizing theme of 'modulators' in clinical neuroscience specifically encompasses:
A. Exclusively voluntary striated muscle contractions.
B. Only the mechanical elasticity of the cranial dura mater.
C. Hormones, immune cytokines, and neurotrophins that adjust circuit sensitivity.
D. Static bone mineral density of the calvarium.
Answer: C
Rationale: Modulators are biological factors—such as endocrine hormones (cortisol, thyroid), immune mediators (cytokines), and
neurotrophic factors (BDNF)—that do not act as primary fast neurotransmitters but instead modify the sensitivity, plasticity, and
survival of neural circuit components.
Q17. Which of the following is NOT an explicit core organizing theme used to scaffold clinical neuroscience?
A. Structural neuroanatomy and localization
B. Modulatory hormonal and immune systems
C. Synaptic chemistry and neurotransmission
D. Unconscious metaphysical drive dynamics
Answer: D
Rationale: The clinical neuroscience framework organizes psychiatry around empirical biological layers: structural neuroanatomy,
cellular circuits, chemical neurotransmission, modulatory systems (hormones/immunity), and behavioral outputs. Metaphysical
Section I: The Neuroscience Model
Chapter 1: Introduction
Chapter 2: Neuroanatomy
Chapter 3: Cells and Circuits
Chapter 4: Neurotransmitters
Chapter 5: Receptors and Signaling the Nucleus
Chapter 6: Genetics and Epigenetics
Section II: Modulators
Chapter 7: Hormones and the Brain
Chapter 8: Plasticity and Adult Development
Chapter 9: Immunity and Inflammation
Chapter 10: The Electrical Brain
Section III: Behaviors
Chapter 11: Pain
Chapter 12: Pleasure
Chapter 13: Appetite
Chapter 14: Anger and Aggression
Chapter 15: Sleep
Chapter 16: Sex and the Brain
Chapter 17: Social Attachment
Chapter 18: Memory
Chapter 19: Intelligence
Chapter 20: Attention
Section IV: Disorders
Chapter 21: Depression
Chapter 22: Anxiety
Chapter 23: Schizophrenia
Chapter 24: Alzheimer’s Disease
,Section I: The Neuroscience Model
Chapter 1: Introduction
Question Quota: 25 MCQs (Q1–Q25) | Question Mix: Mechanism→Symptom (6), Pharmacology (5), Circuitry (5), Discrimination
(3), Case Scenarios (4), Structure/Cascade (2)
Q1. The historical doctrine of mind-brain dualism is clinically problematic in modern psychiatry primarily
because it:
A. Prevents clinicians from identifying the discrete somatic causes of conversion reactions.
B. Restricts psychiatric treatment options exclusively to invasive neurosurgical interventions.
C. Assumes all mental disorders stem from structural chromosomal aneuploidies.
D. Artificially separates psychiatric conditions from verifiable neurobiological dysfunctions.
Answer: D
Rationale: Mind-brain dualism conceptually divorces mental experiences from their underlying physical substrate, creating an
artificial divide between psychiatric and medical illnesses. Modern clinical neuroscience demonstrates that psychiatric symptoms are
direct manifestations of altered neural circuitry, cellular physiology, and neurochemistry, establishing psychiatry as a clinical
neuroscience.
Q2. Framing psychiatric illnesses as disorders of 'pathophysiology' rather than purely psychological reactions is
crucial because it:
A. Ensures that all psychiatric diagnoses can be confirmed via standard laboratory blood tests.
B. Proves that mental illness is caused by macroscopic focal brain tumors.
C. Eliminates the necessity for behavioral therapies in psychiatric treatment plans.
D. Grounds clinical symptoms in identifiable disruptions of neural circuits and molecular cascades.
,Answer: D
Rationale: Conceptualizing psychiatric illnesses through a pathophysiological lens aligns psychiatry with general medicine by
treating behavioral and emotional symptoms as measurable alterations in brain physiology. This mechanistic approach links clinical
phenomena to quantifiable abnormalities in neurotransmitter signaling, neural network connectivity, and neuroplasticity.
Q3. A major clinical limitation of relying solely on the DSM's descriptive diagnostic framework is that it:
A. Mandates invasive neuroimaging prior to assigning any psychiatric diagnosis.
B. Lacks standardized diagnostic criteria across different clinical practice settings.
C. Groups biologically heterogeneous conditions under shared superficial symptom clusters.
D. Overemphasizes underlying neurogenetic etiology at the expense of clinical observation.
Answer: C
Rationale: The DSM relies on descriptive, syndromic criteria rather than etiological mechanisms, meaning patients presenting with
the same categorical diagnosis (such as major depressive disorder) may have distinct underlying biological circuit abnormalities. This
phenomenological grouping limits the ability to target therapies to specific pathophysiology.
Q4. Why does neuroscience serve as the foundational basic science for clinical psychiatry?
A. It demonstrates that every psychiatric symptom originates in a single peripheral nerve.
B. It establishes that psychiatric medications alter mental states without changing neural tissue.
C. It replaces clinical interviews entirely with automated algorithmic scoring.
D. It provides the mechanistic framework for how brain alterations produce disordered behavior.
Answer: D
Rationale: Just as general physiology serves as the foundational science explaining clinical pathology in internal medicine,
neuroscience provides the mechanistic models linking brain anatomy, circuitry, and neurochemistry to psychiatric symptoms.
Understanding these biological principles enables clinicians to understand the rationale behind somatic and psychological
interventions.
Q5. Organizing psychiatric understanding around brain circuits rather than isolated neurotransmitters is essential
because:
, A. Complex behavioral phenotypes emerge from coordinated distributed neural network activity.
B. Circuit models eliminate the role of intracellular second-messenger signaling.
C. Synaptic transmission occurs exclusively through electrical gap junctions without chemical ligands.
D. Neurotransmitters are absent in the central nervous systems of psychiatric patients.
Answer: A
Rationale: Psychiatric functions such as mood regulation, executive control, and threat processing are mediated by distributed,
interconnected neural networks rather than isolated chemical pools. Neurotransmitters act as modulators within these specific circuits,
meaning clinical symptoms reflect network-level circuit dysfunction rather than simple global chemical imbalances.
Q6. How does the biological model of psychiatry conceptualize the relationship between psychotherapy and
neurobiology?
A. Psychotherapy acts exclusively by suppressing hypothalamic endocrine release without cortical involvement.
B. Psychotherapy is considered biologically ineffective compared to surgical lesions.
C. Psychotherapy induces measurable, lasting modifications in neural plasticity and circuit synaptic strength.
D. Psychotherapy works independently of neurobiology without inducing any physical brain changes.
Answer: C
Rationale: The modern biological framework recognizes that learning, psychotherapy, and environmental experiences are biological
events that alter gene expression, synaptic remodeling, and neural circuit connectivity. Functional imaging demonstrates that
successful psychotherapy normalizes dysfunctional neural circuit activity similarly to pharmacotherapy.
Q7. When evaluating psychotropic drug action within a circuit-based framework, pharmacological efficacy
primarily depends on:
A. Irreversibly inhibiting all post-synaptic voltage-gated ion channels.
B. Inducing widespread neuronal apoptosis throughout the subcortical white matter.
C. Maximizing non-specific systemic distribution across non-neuronal organ systems.
D. Altering neurotransmission at specific synapses embedded within symptom-relevant neural loops.
,Answer: D
Rationale: Psychotropic medications exert their therapeutic effects by modulating chemical signaling at critical nodes within
dysfunctional circuits (such as frontostriatal or limbic loops). The therapeutic response is determined by how receptor-level actions
alter overall circuit throughput and downstream gene expression.
Q8. The delayed clinical onset of classical antidepressants, despite rapid reuptake inhibition, illustrates that
therapeutic response involves:
A. Immediate saturation of peripheral plasma albumin binding sites.
B. Permanent elimination of monoamine catabolic enzymes in the liver.
C. Gradual downstream neuroplastic adaptations and intracellular signaling changes.
D. Acute osmotic shifts across the blood-brain barrier endothelial cells.
Answer: C
Rationale: Although monoamine reuptake blockade occurs within hours, clinical improvement requires days to weeks because
therapeutic efficacy depends on downstream neurobiological adaptations. These include receptor down-regulation, cyclic AMP
response element-binding protein (CREB) activation, and brain-derived neurotrophic factor (BDNF) synthesis that restore circuit
integrity.
Q9. A fundamental limitation of the historical 'chemical imbalance' hypothesis of mental illness is that it:
A. Fails to acknowledge that psychotropic drugs bind to central nervous system receptors.
B. Overlooks the complex anatomical distribution and circuit-specific function of neurotransmitters.
C. Assumes neurotransmitters are synthesized exclusively within glial mitochondria.
D. Suggests that psychiatric disorders have higher heritability than neurological diseases.
Answer: B
Rationale: The simplistic 'chemical imbalance' model treats the brain as a homogeneous neurochemical soup, ignoring the fact that
neurotransmitters perform distinct, often opposing functions depending on the specific anatomical circuit and receptor subtype
involved. Effective psychopharmacology requires mapping drug actions onto functional neural circuits.
Q10. Why is understanding receptor subtype diversity critical for modern psychiatric drug development?
, A. It proves that all G-protein-coupled receptors activate identical intracellular pathways.
B. It enables targeting specific circuit components while minimizing off-target adverse effects.
C. It ensures that a single compound can irreversibly block all central nervous system transmission.
D. It eliminates the need to consider drug metabolism in the hepatic cytochrome system.
Answer: B
Rationale: Different receptor subtypes for a given neurotransmitter (e.g., 5-HT1A vs. 5-HT2A) are distributed across distinct brain
regions and couple to different effector cascades. Selective targeting of specific subtypes allows for modulation of targeted neural
pathways while reducing unwanted side effects mediated by other subtypes.
Q11. In the hierarchical neuroscience framework of psychiatry, modulatory systems (such as endocrine and
immune signals):
A. Prevent psychotropic medications from crossing the blood-brain barrier.
B. Operate completely isolated from central neurotransmitter pathways.
C. Directly replace the function of post-synaptic ionotropic receptors.
D. Act as upstream regulators that tune neural circuit excitability and synaptic plasticity.
Answer: D
Rationale: Modulatory systems—including glucocorticoids, gonadal steroids, and circulating cytokines—dynamically adjust the
baseline excitability, gene transcription, and structural plasticity of central neural circuits. Dysregulation in these modulatory systems
can precipitate or exacerbate psychiatric circuit dysfunction.
Q12. Under the organizational architecture of clinical neuroscience, which sequence reflects the hierarchy of
nervous system organization?
A. Modulatory systems → Chemistry → Behaviors → Cells and circuits → Macroscopic structures
B. Chemistry → Behaviors → Macroscopic structures → Cells and circuits → Modulators
C. Macroscopic structures → Cells and circuits → Chemistry → Modulatory systems → Behaviors
D. Behaviors → Modulatory systems → Macroscopic structures → Chemistry → Cells and circuits
,Answer: C
Rationale: The neuroscience framework builds hierarchically from foundational neuroanatomy (macroscopic structures) to
microscopic units (cells and circuits), synaptic transmission (chemistry), systemic tuning (modulators), and ultimately complex
observable phenomena (behaviors and clinical disorders).
Q13. In the circuit-based paradigm of mental illness, psychiatric symptoms are best characterized as:
A. Functional dysregulations within distributed, reciprocal cortico-subcortical loops.
B. Isolated peripheral neuropathies mimicking central nervous system disease.
C. Focal tissue necrosis strictly confined to primary sensory cortices.
D. Static developmental arrests that remain completely immutable to intervention.
Answer: A
Rationale: Psychiatric disorders represent dynamic disruptions in the balance, connectivity, and throughput of cortico-striatal-
thalamo-cortical and limbic-cortical networks. Symptoms reflect dysregulated communication between regulatory cortical regions and
subcortical processing hubs.
Q14. Which structural level provides the essential bridge connecting cellular neurochemistry to clinical behavior?
A. Microvascular capillary basement membranes.
B. Peripheral neuromuscular junction motor endplates.
C. Cerebrospinal fluid osmolarity gradients.
D. Integrated neural circuits and functional networks.
Answer: D
Rationale: Neural circuits and microcircuits integrate cellular and chemical events into functional computational units. These
networks process information and generate the complex cognitive, affective, and motor outputs that constitute human behavior.
Q15. A key premise of circuit-based psychiatry is that distinct psychiatric disorders with overlapping symptoms
frequently share:
, A. Identical macroscopic brainstem infarctions.
B. Common nodes of dysfunction within shared underlying neural networks.
C. Monogenic point mutations on the exact same chromosomal locus.
D. Universal complete absence of cortical gray matter.
Answer: B
Rationale: Symptom overlap across DSM categories (such as executive dysfunction or affective blunting in both depression and
schizophrenia) occurs because disparate pathophysiological processes can converge upon and impair the same underlying neural
circuits (e.g., the frontoparietal or mesocorticolimbic networks).
Q16. The organizing theme of 'modulators' in clinical neuroscience specifically encompasses:
A. Exclusively voluntary striated muscle contractions.
B. Only the mechanical elasticity of the cranial dura mater.
C. Hormones, immune cytokines, and neurotrophins that adjust circuit sensitivity.
D. Static bone mineral density of the calvarium.
Answer: C
Rationale: Modulators are biological factors—such as endocrine hormones (cortisol, thyroid), immune mediators (cytokines), and
neurotrophic factors (BDNF)—that do not act as primary fast neurotransmitters but instead modify the sensitivity, plasticity, and
survival of neural circuit components.
Q17. Which of the following is NOT an explicit core organizing theme used to scaffold clinical neuroscience?
A. Structural neuroanatomy and localization
B. Modulatory hormonal and immune systems
C. Synaptic chemistry and neurotransmission
D. Unconscious metaphysical drive dynamics
Answer: D
Rationale: The clinical neuroscience framework organizes psychiatry around empirical biological layers: structural neuroanatomy,
cellular circuits, chemical neurotransmission, modulatory systems (hormones/immunity), and behavioral outputs. Metaphysical
